SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oncolytics Biotech Reports Durability and Survival Data in Anal Cancer

Oncolytics Biotech reported durability and survival data in anal cancer, describing pelareorep as a potential backbone immunotherapy across HPV-driven cancers.

ONCY

Related stories